Buberl: Private Credit Risks Exist, Axa’s Exposure Remains Low

February 26, 2026 — Axa SA Chief Executive Officer Thomas Buberl addressed growing market concerns about private credit, stressing both the systemic worry in the sector and Axa’s comparatively limited exposure.

Key takeaways

• "Markets are concerned that when things don’t go well in the economy, there could be some fallout from private credit," Thomas Buberl said.
• Buberl stated Axa’s private credit exposure is "far below" that of competitors and attributed that position to having been "very mindful in the past."
• Investors and risk managers should monitor insurer disclosures, portfolio concentration, liquidity profiles and valuation practices to assess private credit vulnerability.

Quick summary

On February 26, 2026, Axa SA’s chief executive emphasized that private credit is a market-wide concern while asserting that Axa’s direct exposure is materially lower than many peers. The remarks highlight a tension: private credit contributes yield and diversification for long-term investors, but it also introduces illiquidity and valuation risk that can surface in downturns.

What is private credit and why it matters to insurers

Private credit refers to non-bank lending outside public debt markets—direct loans, mezzanine financing, unitranche structures and other privately negotiated debt instruments. For insurers, private credit can offer higher yields relative to sovereign and corporate bonds and can match long-duration liabilities. However, these instruments are typically less liquid, less transparent and subject to discrete credit and covenant risks.

Insurers with material allocations to private credit must manage:

• Liquidity risk: private loans can be hard to sell in stressed markets.
• Valuation risk: infrequent pricing can mask mark-to-market losses until stress events.
• Concentration risk: large exposures to a single borrower, sector or sponsor increase vulnerability.
• Funding and mismatch risk: when short-term liabilities meet illiquid assets.

What Buberl said and what it implies

Buberl’s dual message — acknowledging systemic concern while describing Axa’s modest exposure — is deliberately calibrated for institutional investors. The direct quotes make two points that are useful for portfolio managers and analysts:

1. "Markets are concerned that when things don’t go well in the economy, there could be some fallout from private credit." This is a concise, quotable framing of systemic risk: private credit is vulnerable to macro downsides due to weaker borrower cashflows and reduced secondary-market liquidity.

2. Axa’s exposure is "far below" peers because the company had been "very mindful in the past." This is an explicit claim about relative positioning that investors should treat as a starting point for verification in financial disclosures.

Taken together, the statements signal that leading insurers are monitoring private-credit tail risks and positioning balance sheets defensively where managements deem appropriate.

How investors should evaluate insurer exposure (practical checklist)

Institutional investors and analysts can translate Buberl’s comments into a focused due-diligence list:

• Disclosure review: examine annual and interim filings for line-item breakdowns of private credit, loans, direct lending, mezzanine, and alternatives. Look for schedules that separate public fixed-income from private assets.
• Asset-allocation share: confirm the percentage of investable assets or general account assets allocated to private credit or illiquid credit strategies.
• Concentration metrics: identify top borrower exposures, sector concentrations (e.g., real estate, leveraged buyouts) and single-name limits.
• Liquidity profile: assess liquidity buffers (cash, short-term liquid assets) relative to expected outflows and stress scenarios.
• Valuation policy: verify how often private credit is revalued, whether prices use observable inputs or manager models, and the frequency of third-party valuations or audits.
• Covenant and structure quality: look at loan covenants, collateral packages, sponsor strength, and default/litigation exposure.
• Funding and ALM practices: evaluate asset-liability matching and whether insurers rely on stable long-term funding or leverage to hold illiquid credits.

Market implications and analyst angles

• If multiple major insurers confirm low private-credit exposure, market contagion fears may be tempered, which can reduce volatility in credit spreads.
• If peers report higher exposures, watch for differential repricing and capital adequacy impacts across the sector.
• Analysts should model stress scenarios that combine borrower distress with illiquidity to assess potential mark-to-market losses and solvency impacts under adverse macro scenarios.

Practical watchlist (tickers and signals)

• Monitor insurers and financial institutions for changes in private-credit line items and capital ratios; watch tickers such as AM, SA, TV for price reaction and disclosure updates.
• Track liquidity indicators (cash holdings, short-term assets) and any sudden increase in impairments or provisions tied to private credit.

Conclusion

Buberl’s comments on February 26, 2026 succinctly capture the industry debate: private credit is a source of yield but also a potential vector for stress if the economy weakens. His assertion that Axa’s exposure is "far below" competitors and the company’s claim of prior prudence provide a clear, testable statement investors can verify in disclosures. For professional traders, institutional investors and analysts, the priority is to translate management commentary into quantified exposures, concentration measures and stress-test outcomes to form an evidence-based view of sector vulnerability.

Actionable next steps for analysts

1. Pull the latest financial statements and notes on private assets for insurers under coverage.

2. Run scenarios for a macro downturn that includes liquidity shocks in private credit and estimate potential mark-to-market and credit impairment impacts.

3. Compare disclosure language across peers to validate relative exposure claims.

4. Flag any rapid increase in private-credit allocations or reduced covenant protection as potential risk triggers.

By combining management commentary with rigorous disclosure analysis and scenario testing, investors can move from headline risk statements to quantifiable portfolio decisions.